Results 11 to 20 of about 3,193,961 (325)
Candidiasis and Mechanisms of Antifungal Resistance [PDF]
Candidiasis can be present as a cutaneous, mucosal or deep-seated organ infection, which is caused by more than 20 types of Candida sp., with C. albicans being the most common. These are pathogenic yeast and are usually present in the normal microbiome.
Somanon Bhattacharya +3 more
openaire +4 more sources
In vitro antifungal susceptibility methods and clinical implications of antifungal resistance [PDF]
As new antifungal agents are introduced for the treatment of infections caused by yeasts and filamentous fungi (moulds), it is important that reliable methods are available for the in vitro testing of both new and established agents. The ultimate goal of in vitro testing is the prediction of the clinical outcome of therapy.
David W. Warnock +3 more
openaire +4 more sources
An update on antifungal resistance in dermatophytosis
The reports of resistance to antifungal agents used for treating onychomycosis and other superficial fungal infections are increasing. This rise in antifungal resistance poses a public health challenge that requires attention. This review explores the prevalence of dermatophytes and the current relationship between dermatophyte species, their minimum ...
Aditya K. Gupta +3 more
openaire +3 more sources
Mechanisms of resistance to azole antifungals.
Until the late eighties, clinical resistance to azole antifungals was a rare phenomenon. Only a few cases of resistance to ketoconazole were found in patients with chronic mucocutaneous candidiasis (CMC). The spread of AIDS and the widespread prophylactic and therapeutic use of the hydrophilic azole compound fluconazole resulted both in the selection ...
Patrick Marichal, H Vanden Bossche
openaire +5 more sources
Sensitivity and resistance to antifungals [PDF]
D. C. E. Speller, David W. Warnock
openaire +4 more sources
Antifungal Resistance and New Strategies to Control Fungal Infections [PDF]
Despite improvement of antifungal therapies over the last 30 years, the phenomenon of antifungal resistance is still of major concern in clinical practice.
Patrick Vandeputte +2 more
doaj +2 more sources
Antifungal resistance in superficial mycoses
With the widespread use of antifungals to treat superficial mycoses, reports of antifungal resistance are increasing. Antifungal resistance is becoming a public health challenge and needs to be addressed in parallel with antibacterial and antiviral resistance.We review the growing resistance of fungal pathogens such as Trichophyton species and the ...
Aditya K. Gupta, Maanasa Venkataraman
openaire +4 more sources
Antifungal Resistance in Clinical Isolates of Candida glabrata in Ibero-America
In different regions worldwide, there exists an intra-and inter-regional variability in the rates of resistance to antifungal agents in Candida glabrata, highlighting the importance of understanding the epidemiology and antifungal susceptibility profiles
Erick Martínez-Herrera +6 more
doaj +2 more sources
Antifungal resistance on Sporothrix species: an overview [PDF]
The treatment of human and animal sporotrichosis is often performed with antifungal agents; however, the emergence of antifungal-resistant strains of Sporothrix species has been reported. We aimed to discuss the ability of Sporothrix species in developing resistance to the conventional antifungals and mechanisms for this.Published data on databases ...
Stefanie Bressan Waller +5 more
openaire +4 more sources
Time to Think Antifungal Resistance
Increased antifungal resistance is exacerbating the burden of invasive fungal infections, as well as potentially contributing to the increase in resistant dermatomycoses.
Thomas McCormick, Mahmoud Ghannoum
doaj +2 more sources

